References
- ValantineHCardiac allograft vasculopathy after heart transplantation: risk factors and managementJ Heart Lung Transplant2004235 supplS187S19315093804
- SaharaHSekijimaMWakiSIchinariYShimizuAYamadaKHydrogen sulfide (H2S) prevents ischemia–reperfusion injury (IRI) and prolongs survival of the fully MHC-disparate lung graft in CLAWN miniature swineJ Heart Lung Transplant2015344S149
- KoningAMFrenayA-RSLeuveninkHGvan GoorHHydrogen sulfide in renal physiology, disease and transplantation–the smell of renal protectionNitric Oxide201546374925656225
- LobbIDavisonMCarterDHydrogen sulfide treatment mitigates renal allograft ischemia–reperfusion injury during cold storage and improves early transplant kidney function and survival following allogeneic renal transplantationJ Urol201519461806181526239336
- SzaboCRansyCMódisKRegulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanismsBr J Pharmacol201417182099212223991830
- WhitemanMLiLRosePTanC-HParkinsonDBMoorePKThe effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophagesAntioxid Redox Signal201012101147115419769459
- WhitemanMLe TrionnaireSChopraMFoxBWhatmoreJEmerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological toolsClin Sci (Lond)20111211145948821843150
- SlowingIITrewynBGLinVS-YMesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteinsJ Am Chem Soc2007129288845884917589996
- TangHGuoJSunYChangBRenQYangWFacile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug deliveryInt J Pharm2011421238839622001840
- ChenBGuoLFanCCarbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantationAm J Pathol2009175142242919498004
- XingXHeXPengJWangKTanWUptake of silica-coated nanoparticles by HeLa cellsJ Nanosci Nanotechnol20055101688169316245529
- PoberJSJane-WitDQinLTellidesGInteracting mechanisms in the pathogenesis of cardiac allograft vasculopathyArterioscler Thromb Vasc Biol20143481609161424903097
- van den HoogenPHuibersMMSluijterJPde WegerRACardiac allograft vasculopathy: a donor or recipient induced pathology?J Cardiovasc Transl Res20158210611625652948
- YaoL-LHuangX-WWangY-GCaoY-XZhangC-CZhuY-CHydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTPAm J Physiol Heart Circ Physiol20102985H1310H131920154265
- KamatPKKalaniATyagiSCTyagiNHydrogen sulfide epigenetically attenuates homocysteine-induced mitochondrial toxicity mediated through NMDA receptor in mouse brain endothelial (bEnd3) cellsJ Cell Physiol2015230237839425056869
- SzczesnyBMódisKYanagiKAP39 [10-oxo-10-(4-(3-thioxo-3H-1, 2-dithiol-5yl) phenoxy) decyl] triphenylphosphonium bromide], a mitochondrially targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitroNitric Oxide20144112013024755204
- SinghNVan CraeyveldETjwaMCirculating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathyJ Am Coll Cardiol201260432433122813611
- CaiW-JWangM-JMoorePKJinH-MYaoTZhuY-CThe novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylationCardiovasc Res2007761294017631873
- PapapetropoulosAPyriochouAAltaanyZHydrogen sulfide is an endogenous stimulator of angiogenesisProc Natl Acad Sci U S A200910651219722197719955410
- ThoppilRAdapalaRCappelliHParuchuriSMeszarosJGThodetiCTRPV4 channels regulate tumor angiogenesis via modulation of ERK1/2-dependent tumor endothelial cell proliferationFASEB J2015291 suppl796.525404713
- PolhemusDJLeferDJEmergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular diseaseCirc Res2014114473073724526678